Globe Roche Logo

Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus

The rationale for surveillance A burdensome infection In the US alone, staphylococcus aureus (SA) and methicillin resistant staphylococcus aureus (MRSA) infections burden the healthcare system with approximately $9.5 billion and $20 billion in annual care costs, respectively.1,2 Moreover, these staggering …

More

Roche expands cobas® Liat® PCR System menu with launch of cobas® MRSA/SA test to target healthcare-associated infections

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE-IVD launch of the cobas® MRSA/SA nucleic acid test for use on the cobas® Liat® System for the qualitative detection and differentiation of methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) at the point of care.

Explore

cobas® MRSA/SA

Detect MRSA and SA in a single sample in just under 30 minutes, right where it is needed.

More

Roche launches cobas® Liat® PCR System with four assays into CE-markets

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of the cobas® Liat® PCR System with four assays including first 20 minute real-time PCR nucleic acid test to detect Clostridium difficile (C. diff).

Explore

cobas® Cdiff

Combining high assay sensitivity with rapid turnaround time to accurately identify patients suffering from C. difficile-associated disease.

More

Sepsis

Sepsis is a global health problem that carries a high risk of death.1

More

Hospital-acquired infections (HAI)

In developed and developing countries, 7-10% of hospitalized patients will acquire an HAI.1

More

cobas® MRSA/SA Test

Accurately identify patients suffering from C. difficile-associated disease with high assay sensitivity, rapid turnaround time and the flexibility of the cobas® 4800 System.

More

LightCycler® MRSA Advanced Test

Provides accurate and reliable results for the effective prevention and control of MRSA infections

More

LightCycler® MRSA Research Use Only Detection Kit

Ready-to-use detection kit providing primers and HybProbe® Probes for amplification…

More

LightCycler® SeptiFast MecA Test MGRADE

This test is used as an aid in the detection of methicillin resistant Staphylococcus aureus strains.

More

LightCycler® SeptiFast Test MGRADE

Rapid, real-time PCR detection and identification of the most important pathogens causing bloodstream infections, directly from blood.

More

LightCycler® VRE Research Use Only Detection Kit

This kit provides the necessary amplification and detection reagents required for the detection and differentiation of vancomycin resistance genes in Enterococcus spp. (vanA, vanB, vanB2/3) on the LightCycler® 2.0…

More

Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

New test expands menu for healthcare associated infections testing on the widely adopted cobas® 4800...

Explore

Roche receives FDA clearance for next generation cobas MRSA/SA Test

New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide

Explore

Roche launches the cobas® Cdiff Test for detection of Clostridium difficile in markets accepting the CE Mark

New test expands menu for hospital-acquired infections testing on the cobas® 4800 System.

Explore

Roche announces launch of cobas® MRSA/SA Test in markets accepting the CE mark

New test detects methicillin-resistant Staphylococcus aureus and Staphylococcus aureus, the leading causes of healthcare acquired infections worldwide.

Explore

FDA clears Roche’s LightCycler® MRSA Advanced Test for use in the U.S.

Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA)

Explore

Roche to introduce new LightCycler® MRSA Advanced Test in the EU

New test for detection of methicillin-resistant Staphylococcus aureus for better patient care

Explore